Overview
American Vanguard Q2 revenue rises 1% yr/yr, beating analysts' expectations
Adjusted EBITDA for Q2 jumps 80% yr/yr
Company maintains full-year 2025 revenue and EBITDA guidance
Outlook
American Vanguard maintains 2025 revenue guidance of $535 mln to $545 mln
Company reiterates 2025 adjusted EBITDA guidance of $40 mln to $44 mln
American Vanguard sees early stages of recovery in agriculture economy
Company plans to allocate free cash flow towards debt reduction
Result Drivers
OPERATIONAL IMPROVEMENTS - Co attributes 80% increase in adjusted EBITDA to operational improvements and business transformation
MANUFACTURING & PROCUREMENT - Gross profit margin improved due to enhancements in manufacturing and procurement processes
INVENTORY & DEBT REDUCTION - Efficient operations led to decreased inventory and debt levels, per CFO David Johnson
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $129.31 mln | $125 mln (1 Analyst) |
Q2 Net Income | Beat | -$849,000 | -$3.19 mln (1 Analyst) |
Q2 Operating Income | Beat | $4.37 mln | $1.24 mln (1 Analyst) |
Q2 Gross Profit |
| $40.55 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the agricultural chemicals peer group is "buy"
Wall Street's median 12-month price target for American Vanguard Corp is $12.00, about 72% above its July 30 closing price of $3.36
The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 21 three months ago
Press Release: ID:nBw2L8tnta